Target intelligence / Profile preview

Innate immune system sensor

Molecular classification
Receptor, Other
01

Overview

Innate immune system sensors, most commonly referred to as **pattern recognition receptors (PRRs)**, are a diverse group of germline-encoded receptor proteins that detect conserved molecular patterns found in pathogens (PAMPs) and endogenous danger signals (DAMPs)[2][5]. Major classes of these receptors include **Toll-like receptors (TLRs)**, **NOD-like receptors (NLRs)**, **C-type lectin receptors (CLRs)**, **AIM2-like receptors (ALRs)**, **cyclic GMP-AMP synthase (cGAS)**, and **RIG-I-like receptors (RLRs)** such as RIG-I and MDA-5[2][5][3]. Upon activation, these sensors initiate signaling cascades (e.g., via the STING, MAVS, or inflammasome pathways) that lead to rapid induction of type I interferons and other cytokines, development of inflammation, and stimuli for adaptive immune responses[1][3][4][6]. Dysregulation or improper targeting of these pathways can contribute to inflammatory diseases, autoimmunity, or cancer progression[7]. Currently, “innate immune system sensors and pathways” is not a specific molecular target but rather refers to an entire class of innate immune receptors and their associated signaling networks[2][4]; for structured database purposes, these should be mapped to the specific receptor or molecular pathway of interest (e.g., "Toll-like receptor 4" instead of the broad category).

Other names
Pattern recognition receptorPRRinnate immunity sensorinnate immune receptor
02

Mechanism of action

Agonism or antagonism of signal initiation through PRRs (such as Toll-like receptor agonists/antagonists); Inhibition or activation of downstream signaling pathways leading to interferon or cytokine production.

03

Biological functions

Immune responseSignal transductionPathogen recognitionInflammationCell death (depending on pathway, e.g., pyroptosis, necroptosis)Antigen presentation
04

Disease associations

InfectionInflammationCancerAutoimmunity
05

Safety considerations

Increased risk of autoimmunity or excessive inflammation (such as cytokine storm)Risk of immunosuppression if pathways are excessively inhibited
06

Biomarkers

Interferons (e.g., IFN-β, IFN-γ as markers of pathway activation)Proinflammatory cytokines (e.g., IL-6)

Beyond the preview

Go deeper on Innate immune system sensor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune system sensor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call